Cerity Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.33M | Buy |
|
|||||
|
2025
Q2 | $1.06M | Sell |
|
|||||
|
2025
Q1 | $1.51M | Buy |
|
|||||
|
2024
Q4 | $1.6M | Buy |
|
|||||
|
2024
Q3 | $1.58M | Sell |
|
|||||
|
2024
Q2 | $1.54M | Sell |
|
|||||
|
2024
Q1 | $5.72M | Sell |
|
|||||
|
2023
Q4 | $5.58M | Sell |
|
|||||
|
2023
Q3 | $6.01M | Sell |
|
|||||
|
2023
Q2 | $6.96M | Buy |
|
|||||
|
2023
Q1 | $30.7M | Buy |
|
|||||
|
2022
Q4 | $877K | Buy |
|
|||||
|
2022
Q3 | $291K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $207K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $200K | Sell |
|
|||||
|
2021
Q2 | $361K | Hold |
|
|||||
|
2021
Q1 | $361K | Buy |
|
|||||
|
2020
Q4 | $290K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $266K | Hold |
|
|||||
|
2017
Q3 | $271K | Buy |
|
|||||
|
2017
Q2 | $226K | Hold |
|
|||||
|
2017
Q1 | $203K | Buy |
|